Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. (Q46656673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Giuseppe Basso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Franca Fagioli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

R Rondelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

C Rizzari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

A M Testi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

P De Stefano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

F Locatelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

AML Strategy & Study Committee of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

2043-2053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16107897%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403869

5 January 2020

exact match

0 references

cites work

Therapy of childhood acute myelogenous leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403869

7 January 2021